Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets – Do You Anticoagulate?
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Platelets 7,000. Your patient has CAPS (Catastrophic Antiphospholipid Syndrome). Do you anticoagulate?
This is the dilemma every haematologist dreads.
Catastrophic APS (CAPS) throws you into a perfect storm: sky-high thrombotic risk meets dangerous bleeding territory. The instinct is to anticoagulate aggressively. But at 7,000 platelets, that can be fatal.
Here’s the “Bridge to Anticoagulation” approach:
Step 1: HOLD and TRANSFUSE
Stop therapeutic anticoagulation
Give platelet transfusions (unlike TTP, this is safe in CAPS)
Continue immunosuppression and plasma exchange
Step 2: Watch the Safety Window
Platelets <20k: Hold anticoagulation, continue triple therapy
Platelets 20-50k: Consider prophylactic dosing
Platelets >50k: Resume therapeutic anticoagulation
Step 3: Choose UFH
Short half-life, reversible with protamine
Avoid LMWH and warfarin initially
Rule out HIT if platelet recovery stalls
Fourth line: Eculizumab If platelets stay below 20k despite triple therapy, think complement-mediated microangiopathy. Eculizumab can be a lifesaver here.
The bottom line? Don’t let fear of thrombosis push you into fatal bleeding at 7,000. Build the platelet bridge first.
CAPS Task Force recommendations (2020) and real-world experience support this stepwise approach.
Have you managed CAPS with severe thrombocytopenia? What was your strategy?”
More posts from Dr Abdul Mannan on Hemostasis Today.
-
May 25, 2026, 14:04Sophia Delicou: We Aim to Bridge Laboratory Insights and Clinical Practice for Unstable Hemoglobin Variants
-
May 25, 2026, 13:49Chaitanya Harita: Presenting AML Research at the British Society for Haematology Annual Scientific Meeting 2026
-
May 25, 2026, 13:04Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 13:04Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter